We are live on ! Find out more
AAP

Ardsley Advisory Partners Portfolio holdings

AUM $960M
1-Year Est. Return 207.76%
This Fund
S&P 500
This Quarter Est. Return
+19.58%
1 Year Est. Return
+207.76%
3 Year Est. Return
+554.53%
5 Year Est. Return
+728.66%
10 Year Est. Return
+4,084.52%
AUM
$521M
AUM Growth
+$123M
Cap. Flow
+$74M
Cap. Flow %
14.2%
Top 10 Hldgs %
42.06%
Holding
160
New
57
Increased
37
Reduced
27
Closed
29

Top Buys

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$11.3M
2
AMZN icon
Amazon
AMZN
+$11.3M
3
EVA
Enviva Inc.
EVA
+$10.5M
4
MED icon
Medifast
MED
+$10.1M
5
CTLP
Cantaloupe
CTLP
+$8.31M

Top Sells

Rank Stock Value
1
JAZZ icon
Jazz Pharmaceuticals
JAZZ
+$13.6M
2
CVS icon
CVS Health
CVS
+$12.8M
3
RUN icon
Sunrun
RUN
+$11M
4
ADBE icon
Adobe
ADBE
+$10.1M
5
NOW icon
ServiceNow
NOW
+$8.57M

Sector Composition

Rank Sector Weight
1 Technology 26.67%
2 Industrials 16.23%
3 Healthcare 15.24%
4 Consumer Discretionary 7.69%
5 Consumer Staples 4.76%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CBAY
76
DELISTED
Cymabay Therapeutics
CBAY
$544K 0.1%
41,000
+1,000
+3% +$10.6K
GBT
77
DELISTED
Global Blood Therapeutics, Inc.
GBT
$529K 0.1%
+10,000
New +$491K
TTWO icon
78
Take-Two Interactive
TTWO
$46.3B
$519K 0.1%
+5,500
New +$533K
BHVN
79
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$515K 0.1%
+10,000
New +$432K
JPM icon
80
CALL
JPMorgan Chase
JPM
$950B
$506K 0.1%
+5,000
New +$515K
EBAY icon
81
eBay
EBAY
$52.1B
$501K 0.1%
+13,500
New +$468K
CERS icon
82
Cerus
CERS
$585M
$498K 0.1%
80,000
– –
ALXN
83
DELISTED
Alexion Pharmaceuticals
ALXN
$473K 0.09%
+3,500
New +$435K
ALDX icon
84
Aldeyra Therapeutics
ALDX
$95.3M
$470K 0.09%
52,100
– –
ITRI icon
85
Itron
ITRI
$4.75B
$467K 0.09%
+10,000
New +$531K
ACER
86
DELISTED
Acer Therapeutics Inc
ACER
$437K 0.08%
18,000
-2,000
-10% -$47.2K
RP
87
DELISTED
RealPage, Inc.
RP
$425K 0.08%
+7,000
New +$401K
ELAN icon
88
Elanco Animal Health
ELAN
$12.7B
$419K 0.08%
+13,068
New +$402K
BBBY
89
Bed Bath & Beyond
BBBY
$503M
$416K 0.08%
+33,275
New +$455K
MSFT icon
90
PUT
Microsoft
MSFT
$2.92T
$413K 0.08%
+3,500
New +$382K
IEA
91
DELISTED
Infrastructure and Energy Alternatives, Inc. Common Stock
IEA
$411K 0.08%
+78,477
New +$573K
ALDR
92
DELISTED
Alder Biopharmaceuticals
ALDR
$410K 0.08%
+30,000
New +$389K
PCTY icon
93
Paylocity
PCTY
$7.43B
$401K 0.08%
+4,500
New +$350K
ACIA
94
DELISTED
Acacia Communications Inc
ACIA
$401K 0.08%
+7,000
New +$335K
HROW icon
95
Harrow
HROW
$1.47B
$374K 0.07%
75,000
– –
GRDX
96
GridAI Technologies Corp
GRDX
$21M
$363K 0.07%
1
– –
SSYS icon
97
Stratasys
SSYS
$690M
$357K 0.07%
+15,000
New +$361K
RGNX icon
98
Regenxbio
RGNX
$615M
$344K 0.07%
+6,000
New +$297K
STAA icon
99
STAAR Surgical
STAA
$1.13B
$342K 0.07%
+10,000
New +$354K
TUSK icon
100
Mammoth Energy Services
TUSK
$125M
$333K 0.06%
+20,000
New +$427K
2 3
4
5 6

Similar funds

NA
Navellier & Associates Reno, Nevada $960M AUM 79.37% 1-Year Est. Return
MK
MASTERINVEST Kapitalanlage Vienna $962M AUM 27.59% 1-Year Est. Return
QIM
Quantitative Investment Management Charlottesville, Virginia $963M AUM 12.95% 1-Year Est. Return
JVBC
J.V. Bruni & Co Colorado Springs, Colorado $958M AUM 22.2% 1-Year Est. Return
TFP
Triple Frond Partners San Francisco, California $963M AUM 27.45% 1-Year Est. Return
UWPG
Ullmann Wealth Partners Group Jacksonville Beach, Florida $963M AUM 17.06% 1-Year Est. Return
LOAMU
Lombard Odier Asset Management (USA) New York $957M AUM 35.8% 1-Year Est. Return
PHS
Pekin Hardy Strauss Chicago, Illinois $957M AUM 44.61% 1-Year Est. Return

Ardsley Advisory Partners's Q1 2019 Portfolio in Review

As of Q1 2019, Ardsley Advisory Partners held 160 positions worth $521M, up 31% from $398M the previous quarter. Its ten largest holdings account for 42% of the portfolio.

Ardsley Advisory Partners deployed $74M of net new capital in Q1 2019, opening 57 new positions and adding to 37 existing holdings. Its largest new stake was Medifast: 80,000 shares worth $10.2M.

By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 30% a quarter earlier, followed by Industrials and Healthcare.

On the sell side, the largest reduction was Sunrun, an estimated $11M trimmed.

  • Ardsley Advisory Partners's largest Q1 2019 buy was Medifast: 80,000 shares worth $10.2M.
  • Ardsley Advisory Partners added most to Celgene Corp in Q1 2019, an estimated $11.3M increase.
  • Ardsley Advisory Partners's biggest Q1 2019 reduction was Sunrun, cutting an estimated $11M.
  • Ardsley Advisory Partners fully exited Jazz Pharmaceuticals in Q1 2019, selling an estimated $13.6M.
  • Ardsley Advisory Partners's ten largest holdings make up 42% of its $521M portfolio in Q1 2019.
  • Ardsley Advisory Partners opened 57 new positions and closed 29 in Q1 2019.
  • Ardsley Advisory Partners's portfolio value rose 31% quarter-over-quarter to $521M.

Based on Ardsley Advisory Partners's 13F filing for Q1 2019, filed 15 May 2019.